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Heat Shock Protein 90 (Hsp90) is an essential chaperone that supports
the function of a wide range of signaling molecules. Hsp90 binds to a
suite of co-chaperone proteins that regulate Hsp90 function through
alteration of intrinsic ATPase activity. Several studies have determined
Aha1 to be an important co-chaperone whose binding to Hsp90 is
modulated by phosphorylation, acetylation and SUMOylation of Hsp90
[1,2]. In this study, we applied quantitative afﬁnity-puriﬁcation mass
spectrometry (AP-MS) proteomics to understand how phosphorylation
of hAha1 at Y223 altered global client/co-chaperone interaction [3].
Speciﬁcally, we characterized and compared the interactomes of
Aha1–Y223F (phospho-mutant form) and Aha1–Y223E (phospho-
mimic form). We identiﬁed 99 statistically signiﬁcant interactors of
hAha1, a high proportion of which (84%) demonstrated preferential
binding to the phospho-mimic form of hAha1.
The mass spectrometry proteomics data have been deposited to
the ProteomeXchange Consortium (http://proteomecentral.proteo-
mexchange.org) via the PRIDE partner repository [4] with the dataset
identiﬁer PXD001737.
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
ical Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223,
an).
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via the PRIDE partner repository with the dataset identiﬁer PXD001737.Value of the data This data provides a comprehensive interactome of human Aha1.
 This study examines the Aha1 interactome quantitatively 7Y223 phosphorylation.
 Identiﬁes important client and co-chaperone proteins that are speciﬁcally altered by Y223
phosphorylation.
 Demonstrates a novel method for regulating Hsp90 function, a key molecule in cancer
proliferation.1. Experimental design, materials and methods
HEK293 cell lines expressing either hAha1–Y223F–FLAG or Y223E–FLAG were grown in Dulbecco's
modiﬁed Eagle's minimal essential medium (DMEM, Invitrogen) supplemented with 10% fetal bovine
serum [1–4]. All cell lines were propagated at 37 °C in an atmosphere containing 5% CO2. Protein
extraction from both HEK293 cells was carried out using methods previously described [5]. For
immunoprecipitation, mammalian cell lysates were incubated with anti-FLAG antibody conjugated
magnetic beads (Sigma) for 2 h at 4 °C and washed 4 times with fresh lysis buffer (20 mM Tris (pH
7.5), 100 mM NaCl, 1 mMMgCl2, 0.1% NP40, Protease and Phosphatase inhibitor mini tablet, EDTA-free
(Pierce). hAha1 complexes were eluted with FLAG peptide (Apex Bio).2. LC–MS/MS data acquisition
2.1. Trypsin digestion of hAha1–FLAG complexes from SDS-PAGE gels
After hAha1 complexes were obtained, samples were processed as in [6,7]. Puriﬁed hAha1–Y223F–
FLAG or Y223E–FLAG complexes were loaded onto a 12% MOPS buffered SDS-PAGE gel (Invitrogen)
and run for 10 min at 200 v resulting in a 2 cm “gel plug”. The gel was stained with 25 mL Imperial
Stain (Pierce) at room temperature, and destained overnight in dH2O at 4 °C. The gel plugs for each
sample to be analyzed were excised by sterile razor blade, divided into 2 sections 1 cm each, and
chopped into 1 mm3 pieces. Each section was washed in dH2O and destained using 100 mM
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NH4HCO3 pH 7.5 and 10 μl of 200 mM tris (2-carboxyethyl) phosphine HCl at 37 °C for 30 min. The
proteins were alkylated by addition of 100 μl of 50 mM iodoacetamide prepared fresh in 50 mM
NH4HCO3 pH 7.5 buffer, and allowed to react in the dark at 20 °C for 30 min. Gel sections were washed
in water, then acetonitrile, and vacuum dried. Trypsin digestion was carried out overnight at 37 °C
with 1:50–1:100 enzyme–protein ratio of sequencing grade-modiﬁed trypsin (Promega) in 50 mM
NH4HCO3 pH 7.5, and 20 mM CaCl2. Peptides were extracted with 5% formic acid and vacuum dried.
2.2. Isotopic labeling of trypsin-digested hAha1–FLAG complexes
Peptide digests were reconstituted with 70 μl of Tris–HCl buffer solution (10 mM of Tris–HCl,
150 mM NaCl, 20 mM CaCl2, pH 7.6), vortexed for at least 20 min to reconstitute the peptide mixture,
then split into two vials of 30 μl each (16O vial and 18O vial), and 10 μl was retained unlabeled and
stored in 80 °C. In a separate vial Mag-Trypsin beads (Clontech) were prepared as follows. 30 μl
Mag-trypsin beads per rxn (16O or 18O) were pooled and washed 3 times with 800 μl of Tris–HCl
Buffer Solution, then brought back up in 30 μl/sample of Tris–HCl buffer, and aliquoted to a new 1.5 ml
vial in the quantity of 30 μl, vortexing lightly after each aliquot to keep the Mag-trypsin beads in
suspension. Using a magnetic rack, the Tris–HCl buffer was removed from the beads, and the 30 μl of
sample digest from above was added to the beads and vacuum dried. 30 μl of either 16O H2O or 97%
18O H2O (Cambridge Isotopes Laboratories) was added to the respective 16O or 18O prepared Mag-
Trypsin bead vial and vortexed for 20 min to reconstitute the peptide mixture, and allowed to
exchange overnight at 37 °C. After 18O exchange, the solution was transferred to a new vial and any
free trypsin in solution was inactivated with 1 mM PMSF for 30 min at 4 °C. For each sample section,
the AHA-1 (E/F) digests were combined 1:1 as follows: Forward (FWD) Sample Set: (F)-16O:(E)-18O
and Reversed (REV) Sample Set: (E)-16O:(F)-18O, dried and stored at 80 °C until analysis. Three
biological replicate experiments were performed.
2.3. HPLC for mass spectrometry
All samples were re-suspended in Burdick & Jackson HPLC-grade water containing 0.2% formic acid
(Fluka), 0.1% TFA (Pierce), and 0.002% Zwittergent 3–16 (Calbiochem), a sulfobetaine detergent that
contributes the following distinct peaks at the end of chromatograms: MHþ at 392, and in-source
dimer [2MþHþ] at 783, and some minor impurities of Zwittergent 3–12 seen as MHþ at 336. The
peptide samples were loaded to a 0.25 μl C8 OptiPak trapping cartridge custom-packed with Michrom
Magic (Optimize Technologies) C8, washed, then switched in-line with a 20 cm by 75 μm C18 packed
spray tip nanocolumn packed with Michrom Magic C18AQ, for a 2-step gradient. Mobile phase A was
water/acetonitrile/formic acid (98/2/0.2) and mobile phase B was acetonitrile/isopropanol/water/
formic acid (80/10/10/0.2). Using a ﬂow rate of 350 nl/min, a 90 min, 2-step LC gradient was run from
5% B to 50% B in 60 min, followed by 50–95% B over the next 10 min, hold 10 min at 95% B, back to
starting conditions and re-equilibrated.
2.4. LC–MS/MS analysis
The samples were analyzed via electrospray tandem mass spectrometry (LC–MS/MS) on a Thermo
Q-Exactive Orbitrap mass spectrometer, using a 70,000 RP survey scan in proﬁle mode, m/z 360–
2000 Da, with lockmasses, followed by 10 MSMS HCD fragmentation scans at 17,500 resolution on
doubly and triply charged precursors. Single charged ions were excluded, and ions selected for MS/MS
were placed on an exclusion list for 60 s.
2.5. LC–MS/MS data analysis, statistical analysis
All LC–MS/MS *.raw Data ﬁles were analyzed with MaxQuant version 1.2.2, searching against the
SPROT Human database using the following criteria: 18O heavy label was selected for quantitation
with a min of 1 high conﬁdence peptide to assign quantitation H/L ratio. Trypsin was selected as the
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Variable modiﬁcations were set to Oxidization (M), Formylation (n-term), and Phosphorylation (STY).
Orbitrap mass spectrometer was selected using an MS error of 20 ppm and a MS/MS error of 0.5 Da.
1% FDR cutoff was selected for peptide, protein, and site identiﬁcations.
Ratios were reported based on the MS level light and heavy peak areas determined by MaxQuant
and reported in the proteinGroups.txt ﬁle as heavy/light or (hAha1–Y223E/hAha1–Y223F mutant).
Proteins were removed from this results ﬁle if they were ﬂagged by MaxQuant as “Contaminants”,
“Reverse” or “Only identiﬁed by site”. Complete three biological replicates were performed, with each
biological replicate split into two technical replicates (18O forward (FWD) labeling, and 18O reverse
(REV) labeling). The abundance data from each biological replicate were normalized to the ratio of the
bait protein in that run (e.g. normalized to the hAHA1–FLAG ratio). Light and Heavy peak intensities
were analyzed in each run to determine protein hits that fell into the category of either hAha1–
Y223E-only hits or hAha1–Y223F-only hits and retained if they conﬁrmed to this state across all
6 runs. In the case of hAha1–Y223E-only or hAha1–Y223F-only protein hits, spectra counts can be
used as a proxy for abundance as these would not of been assigned a quantitation ratio. This produced
a list of hAha1 interactors and their respective quantitated changes between hAha1–Y223F and
hAha1–Y223E.
Further statistical analysis was performed using the R statistical package (http://www.r-project.
org/). Proteins with three out of the six observations were retained. Missing values were imputed
using row mean imputation. An ANOVA test was then performed to identify proteins that indicate
signiﬁcant variability (P-valueo0.05) between biological replicates within each group. The mass
spectrometry proteomic data have been deposited to the ProteomeXchange Consortium (http://pro
teomecentral.proteomexchange.org) via the PRIDE partner repository (REF A) with the dataset
identiﬁer PXD001737.Acknowledgments
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